The Multicenter Uveitis Steroid Treatment Trial: Rationale, Design, and Baseline Characteristics

American Journal of Ophthalmology

Volumn 149, Issue 4, 2010, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

FLUOCINOLONE ACETONIDE; PREDNISONE;

ADULT; ARTICLE; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIRETINAL MEMBRANE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA EDEMA; UVEITIS; VISUAL ACUITY;

EID: 77949657394     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.11.019     Document Type: Article

References (66)

1. Durrani O.M., Meads C.A., and Murray P.I. Uveitis: a potentially blinding disease. Ophthalmologica 218 (2004) 223-236
2. Nussenblatt R.B. The natural history of uveitis. Int Ophthalmol 14 (1990) 303-308
3. ten Doesschate J. Causes of blindness in The Netherlands. Doc Ophthalmol 52 (1982) 279-285
4. National Advisory Eye Council. Vision Research. A National Plan, 1983-1987 (1983), National Institutes of Health, Public Health Service, US Department of Health and Human Services, Bethesda, MD 13
5. Durrani O.M., Tehrani N.N., Marr J.E., Moradi P., Stavrou P., and Murray P.I. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol 88 (2004) 1159-1162
6. Bloch-Michel E., and Nussenblatt R.B. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 103 (1987) 234-235
7. Jabs D.A., Nussenblatt R.B., and Rosenbaum J.T. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140 (2005) 509-516
8. Rothova A., Suttorp-van Schulten M.S., Frits Treffers W., and Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80 (1996) 332-336
9. Henderly D.E., Genstler A.J., Smith R.E., and Rao N.A. Changing patterns of uveitis. Am J Ophthalmol 103 (1987) 131-136
10. McCannel C.A., Holland G.N., Helm C.J., Cornell P.J., Winston J.V., and Rimmer T.G. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 121 (1996) 35-46
11. Mercanti A., Parolini B., Bonora A., Lequaglie Q., and Tomazzoli L. Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases. Acta Ophthalmol Scand 79 (2001) 64-68
12. Merrill P.T., Kim J., Cox T.A., Betor C.C., McCallum R.M., and Jaffe G.J. Uveitis in the southeastern United States. Curr Eye Res 16 (1997) 865-874
13. Palmares J., Coutinho M.F., and Castro-Correia J. Uveitis in northern Portugal. Curr Eye Res 9 Suppl (1990) 31-34
14. Perkins E.S., and Folk J. Uveitis in London and Iowa. Ophthalmologica 189 (1984) 36-40
15. Pivetti-Pezzi P., Accorinti M., La Cava M., Colabelli Gisoldi R.A., and Abdulaziz M.A. Endogenous uveitis: an analysis of 1,417 cases. Ophthalmologica 210 (1996) 234-238
16. Rodriguez A., Calonge M., Pedroza-Seres M., et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 114 (1996) 593-599
17. Rothova A., Buitenhuis H.J., Meenken C., et al. Uveitis and systemic disease. Br J Ophthalmol 76 (1992) 137-141
18. Santin M., Badrinas F., Mascaro J., et al. Uveitis: an etiological study of 200 cases following a protocol [in Spanish]. Med Clin (Barc) 96 (1991) 641-644
19. Smit R.L., Baarsma G.S., and de Vries J. Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int Ophthalmol 17 (1993) 71-76
20. Tran V.T., Auer C., Guex-Crosier Y., Pittet N., and Herbort C.P. Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol 18 (1994) 293-298
21. Foster C.S., and Vitale A.T. Diagnosis and Treatment of Uveitis (2002), W. B. Saunders Company, Philadelphia
22. Jabs D.A., Rosenbaum J.T., Foster C.S., et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130 (2000) 492-513
23. Nussenblatt R.B., Whitcup S.M., and Palestine A.G. Uveitis. Fundamentals and Clinical Practice (1996), Mosby, St. Louis
24. Callanan D.G., Jaffe G.J., Martin D.F., Pearson P.A., and Comstock T.L. Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol 126 (2008) 1191-1201
25. Jaffe G.J., Martin D., Callanan D., Pearson P.A., Levy B., and Comstock T. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology 113 (2006) 1020-1027
26. Jaffe G.J., Ben Nun J., Guo H., Dunn J.P., and Ashton P. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology 107 (2000) 2024-2033
27. Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. Cost-effectiveness in health and medicine (1996), Oxford University Press, New York
28. Goldstein D.A., Godfrey D.G., Hall A., et al. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. Arch Ophthalmol 125 (2007) 1478-1485
29. Beck R.W., Maguire M.G., Bressler N.M., Glassman A.R., Lindblad A.S., and Ferris F.L. Visual acuity as an outcome measure in clinical trials of retinal diseases. Ophthalmology 114 (2007) 1804-1809
30. Ferris III F.L., Kassoff A., Bresnick G.H., and Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 94 (1982) 91-96
31. Gragoudas E.S., Adamis A.P., Cunningham Jr. E.T., Feinsod M., and Guyer D.R. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 (2004) 2805-2816
32. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol 131 (2001) 541-560
33. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. one-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol 117 (1999) 1329-1345
34. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 109 (1991) 1220-1231
35. Zeger S.L., and Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42 (1986) 121-130
36. Ryan P. sxd1_4: random allocation of treatments in blocks. Stata J 8 (2008) 146
37. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 44 (2001) 1496-1503
38. Ferris III F.L., and Bailey I. Standardizing the measurement of visual acuity for clinical research studies: guidelines from the Eye Care Technology Forum. Ophthalmology 103 (1996) 181-182
39. Brooks R. EuroQol: the current state of play. Health Policy 37 (1996) 53-72
40. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16 (1990) 199-208
41. Brazier J.E., Harper R., Jones N.M., et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305 (1992) 160-164
42. Jenkinson C., Wright L., and Coulter A. Criterion validity and reliability of the SF-36 in a population sample. Qual Life Res 3 (1994) 7-12
43. Mangione C.M., Lee P.P., Gutierrez P.R., Spritzer K., Berry S., and Hays R.D. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 119 (2001) 1050-1058
44. Hogan M.J., Kimura S.J., and Thygeson P. Signs and symptoms of uveitis. I. Anterior uveitis. Am J Ophthalmol 47 (1959) 155-170
45. Mangione C.M., Lee P.P., Pitts J., Gutierrez P., Berry S., and Hays R.D. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol 116 (1998) 1496-1504
46. Coons S.J., Rao S., Keininger D.L., and Hays R.D. A comparative review of generic quality-of-life instruments. Pharmacoeconomics 17 (2000) 13-35
47. Musch D.C., Lichter P.R., Guire K.E., and Standardi C.L. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology 106 (1999) 653-662
48. Asman P., and Heijl A. Glaucoma Hemifield Test. Automated visual field evaluation. Arch Ophthalmol 110 (1992) 812-819
49. Sommer A., Tielsch J.M., Katz J., et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 109 (1991) 1090-1095
50. Age-Related Eye Disease Study Research Group. The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. Am J Ophthalmol 131 (2001) 167-175
51. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
52. Osteoporosis. review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Status Report. Osteoporos Int 8 Suppl 4 (1998) S3-S6
53. Miller P.D. Bisphosphonates for the prevention and treatment of corticosteroid-induced osteoporosis. Osteoporos Int 12 Suppl 3 (2001) S3-S10
54. Kanis J.A., and WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 4 (1994) 368-381
55. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
56. Lloyd-Jones D.M., Evans J.C., Larson M.G., O'Donnell C.J., and Levy D. Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 34 (1999) 381-385
57. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157 (1997) 2413-2446
58. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (2000), American Psychiatric Association, Washington, DC
59. Hanmer J., Lawrence W.F., Anderson J.P., Kaplan R.M., and Fryback D.G. Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Making 26 (2006) 391-400
60. Kacmaz R.O., Kempen J.H., Newcomb C.W., et al. Ocular inflammation in Behçet's disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol 146 (2008) 828-836
61. Thorne J.E., Jabs D.A., Peters G.B., Hair D., Dunn J.P., and Kempen J.H. Birdshot retinochoroidopathy: ocular complications and visual impairment. Am J Ophthalmol 140 (2005) 45-51
62. Brown M.M., Brown G.C., Sharma S., and Busbee B. Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology 110 (2003) 1076-1081
63. Jaffe G.J., McCallum R.M., Branchaud B., Skalak C., Butuner Z., and Ashton P. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Ophthalmology 112 (2005) 1192-1198
64. BenEzra D., Cohen E., Chajek T., et al. Evaluation of conventional therapy versus cyclosporine A in Behcet's syndrome. Transplant Proc 20 (1988) 136-143
65. Thorne J.E., Wittenberg S., Jabs D.A., et al. Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity. Ophthalmology 113 (2006) 2310-2316
66. Yazici H., Pazarli H., Barnes C.G., et al. A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med 322 (1990) 281-285